These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Demonstration of the abnormal lipoprotein of cholestasis, LP-X, by precipitation with polyanion. Ritland S Scand J Gastroenterol; 1974; 9(5):507-10. PubMed ID: 4604299 [No Abstract] [Full Text] [Related]
26. [Metabolic changes of cholestatic lipoprotein (LP-X) in the diagnosis of biliary atresia]. Poley JR; Magnani HN; Alaupovic P Cesk Pediatr; 1978 Dec; 33(12):713-4. PubMed ID: 743758 [No Abstract] [Full Text] [Related]
27. [Lipoprotein-X and other clinico-chemical parameters in cholestasis]. Mayr K Wien Med Wochenschr; 1976 Jun; 126(25-27):378-80. PubMed ID: 10681 [No Abstract] [Full Text] [Related]
28. Plasma concentration of lipoprotein-X (LP-X) in experimental bile duct obstruction. Ritland S; Bergan A Scand J Gastroenterol; 1975; 10(1):17-24. PubMed ID: 1124340 [TBL] [Abstract][Full Text] [Related]
29. [Lipoprotein-X. Methods of analysis and diagnostic significance in cholestasis]. Raabo E; Franck C; Frey M; Ingwersen S Ugeskr Laeger; 1980 Jul; 142(31):1986-9. PubMed ID: 7404816 [No Abstract] [Full Text] [Related]
30. [Quantitative determination of lipoprotein-X (LP-X) in extrahepatic cholestasis and intrahepatic cholestasis]. Calvo C; Arroqui I Rev Med Chil; 1984 Mar; 112(3):233-7. PubMed ID: 6473964 [No Abstract] [Full Text] [Related]
31. [Study of an abnormal lipoprotein (LP-X) associated with cholestasis]. Vergani C; Pietrogrande M; Grondona MC; Pizzolato M Minerva Med; 1973 Apr; 64(28):1461-85. PubMed ID: 4196357 [No Abstract] [Full Text] [Related]
32. Diagnosis of extrahepatic biliary obstruction in infants by immunochemical detection of LP-X and modified 131 I-Rose Bengal excretion test. Poley JR; Alaupovic P; McConathy WJ; Seidel D; Roy CC; Weber A J Lab Clin Med; 1973 Mar; 81(3):325-41. PubMed ID: 4346964 [No Abstract] [Full Text] [Related]
33. [Diagnostic value of lipoprotein x determination in gallbladder and bile ducts diseases]. UmiĆska H; Palynyczko Z Pol Tyg Lek; 1976 May; 31(18):765-8. PubMed ID: 951222 [No Abstract] [Full Text] [Related]
34. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat. Walli AK; Seidel D J Clin Invest; 1984 Sep; 74(3):867-79. PubMed ID: 6470142 [TBL] [Abstract][Full Text] [Related]
35. [Diagnostic approach and treatment of neonates and children cholestasis]. Mention K; Dobbelaere D; Gottrand F Arch Pediatr; 2007 Jun; 14(6):569-72. PubMed ID: 17446052 [No Abstract] [Full Text] [Related]
36. Value of prednisone test in the differential diagnosis of viral hepatitis and extrahepatic biliary obstruction. Misra MP; Barat AK; Pathak L; Tejwani BM; Singh S J Assoc Physicians India; 1973 Feb; 21(2):211-3. PubMed ID: 4792796 [No Abstract] [Full Text] [Related]
37. [Differential diagnostic importance of blood serum polarography in viral hepatitis and obstructive jaundice]. Irt'iakov VR Vrach Delo; 1982 Jun; (6):107-9. PubMed ID: 7113156 [No Abstract] [Full Text] [Related]
38. [LP-X and hypercholesterolemia caused by cholestasis]. Picard J; Veissiere D Med Chir Dig; 1978; 7(2):143-7. PubMed ID: 661409 [No Abstract] [Full Text] [Related]
39. [Cholestasis assessment by activity of antioxidant enzymes and composition of plasma lipoproteins in patients with liver diseases]. Loginov AS; Matiushin BN; Chebanov SM; Reshetniak VI Ter Arkh; 1998; 70(4):40-2. PubMed ID: 9612901 [TBL] [Abstract][Full Text] [Related]
40. Recent advances in diagnosis and treatment of cholestatic jaundice. Gebhard RL; Vennes JA Geriatrics; 1980 Aug; 35(8):43-51, 54. PubMed ID: 7409473 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]